<DOC>
	<DOCNO>NCT01549847</DOCNO>
	<brief_summary>This protocol aim assess L-carnitine piracetam relieve weakness , muscle fatigue muscle pain patient Postpoliomyelitis Syndrome .</brief_summary>
	<brief_title>A Randomized , Double Blind , Placebo Controlled Trial L-carnitine Piracetam Treatment Weakness , Muscle Fatigue Muscle Pain Postpoliomyelitis Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Postpoliomyelitis Syndrome</mesh_term>
	<mesh_term>Muscle Weakness</mesh_term>
	<criteria>Patients Postpoliomyelitis Syndrome diagnosis confirm year ; Electromyography test compatible poliomyelitis ; Preserved ability swallow medication ; Oral communication ability preserve ; Preserved ability perform pedal test least one low limb affect Postpoliomyelitis Syndrome ; Ability understand information study document decision participate trial signing Informed Consent Form . History intolerance Lcarnitine piracetam ; Treatment Lcarnitine past 3 month ; Treatment piracetam nootropics pyrrolidone derivative , past three month ; Anemia ( hemoglobin reference range men 13 17 g/dL woman 12 15 g/dL ) ; High level glycated hemoglobin ( &gt; 7.0 % ) ; Electrolyte imbalance ( hypokalaemia reference potassium concentration range : 3.5 5.6 mmol / L ) ; Renal failure ( creatinine reference range : 0.70 1.50 mg/dL ) ; Urinary tract infection ; Thyroid dysfunction ( reference range : free T4 : 0.54 0.67 mg/dL TSH reference range : 0.5 5.5 Î¼UI/mL ) usual treatment thyroid hormone supplementation ; Cardiomyopathy ; Uncontrolled hypertension ; Known suspect autoimmune disease ; Confirmed pregnancy , plan get pregnant trial ; Depression bipolar affective disorder moderate severe episode within last twelve month ; Insulindependent diabetes mellitus ; Treatment anticoagulant drug two week ( include nonsteroidal antiinflammatory drug ( NSAIDs ) , warfarin , phenprocoumon , heparin ) ; Usual cocaine alcohol use ; Any condition judge investigator possibility interfere participant 's decision part study accomplish investigation procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Postpoliomyelitis Syndrome</keyword>
	<keyword>Piracetam</keyword>
	<keyword>L-Carnitine</keyword>
</DOC>